Program Schedule

92
Progress Toward A Cure for HIV

Friday, October 10, 2014: 10:30 AM-12:00 PM
Room: The Pennsylvania Convention Center: 103-ABC

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • summarize the state of HIV cure research
  • explain the potential clinical applications of the latest cure science
  • identify opportunities and challenges to conducting cure clinical trials

Target Audience: Public health practitioners, Members-in-training, Infectious diseases physicians, HIV specialists, HIV clinicians, Fellows, Clinicians

Tracks: HIV-STD-TB

Moderator:  Pablo Tebas, MD, Perelman School of Medicine, University of Pennsylvania

Presentations:
10:30 AM
623
NIH Initiatives Toward a Cure
Carl Dieffenbach, PhD
11:30 AM
624
Cure: From Bench to Bedside
Joseph Eron, MD

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-14-120-L02-P

Disclosures:

P. Tebas, None

C. Dieffenbach, None

J. Eron, Merck : Consultant, Consulting fee
Bristol MyersSquibb: Consultant and Investigator, Consulting fee and Research support
Gilead: Consultant, Consulting fee

D. M. Margolis, Merck: Consultant, Consulting fee
GSK: Consultant, Consulting fee
Chimerix: Consultant, Consulting fee
Argos : Research Contractor, Research support
Gilead, Abbott, Abbvie: Common Stock , Common Stock

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, idweek.org. All Rights Reserved.

Follow IDWeek